Akorn, Inc.  

(Public, NASDAQ:AKRX)   Watch this stock  
Find more results for AKRX
+0.36 (1.31%)
After Hours: 27.78 0.00 (0.00%)
Sep 27, 5:58PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 27.20 - 27.96
52 week 17.57 - 39.46
Open 27.39
Vol / Avg. 802,819.00/1.17M
Mkt cap 3.67B
P/E 18.59
Div/yield     -
EPS 1.49
Shares 126.03M
Beta 1.08
Inst. own 91%
Sep 13, 2016
Akorn Inc at Morgan Stanley Global Healthcare Conference
Aug 4, 2016
Q2 2016 Akorn Inc Earnings Call - Webcast
Aug 4, 2016
Q2 2016 Akorn Inc Earnings Release
Jul 1, 2016
Akorn Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 22.08% 15.31%
Operating margin 32.90% 29.99%
EBITD margin - 42.00%
Return on average assets 13.19% 7.66%
Return on average equity 34.42% 30.84%
Employees 1,972 -
CDP Score - -


1925 W Field Ct Ste 300
LAKE FOREST, IL 60045-4862
United States - Map
+1-847-2796100 (Phone)
+1-800-9433694 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Akorn Inc., together with its subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment is engaged in manufacturing and marketing generic and branded prescription pharmaceuticals, including ophthalmics, injectables, oral liquids, otics, topical, inhalants and nasal sprays. The Consumer Health segment is engaged in manufacturing and marketing branded and private-label animal health and OTC products. The Company's Akorn Consumer Health division (ACH) markets a portfolio of OTC brands and various formulations of private-label OTC pharmaceutical products. Its OTC brand is TheraTears Therapy for Your Eyes, which is a family of therapeutic eye care products.

Officers and directors

John N. Kapoor Ph.D. Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Rajat Rai Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Duane A. Portwood Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Bruce Kutinsky Ph.D. Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Randall E. Pollard Executive Vice President, Corporate Controller,Chief Accounting Officer
Age: 44
Bio & Compensation  - Reuters
Jonathon Kafer Executive Vice President - Sales and Marketing
Age: 53
Bio & Compensation  - Reuters
Steven Joseph Lichter Executive Vice President - Pharmaceutical Operations
Age: 57
Bio & Compensation  - Reuters
Joseph P. Bonaccorsi Senior Vice President, General Counsel, Secretary
Age: 51
Bio & Compensation  - Reuters
Rob Monahan Senior Vice President of Corporate Development
Bio & Compensation  - Reuters
Brian Tambi Director
Age: 71
Bio & Compensation  - Reuters